Aetna Tocilizumab (Actemra) prior authorization requirements (2026)
What Aetna generally requires to approve Tocilizumab (Actemra) (CPT J3262), for Commercial plans. Yes. Aetna generally requires prior authorization for Tocilizumab (Actemra) (CPT J3262).
Medical-necessity criteria Aetna generally applies
Precertification required (prescribed by/with a rheumatologist for RA, GCA, polymyalgia rheumatica, or JIA). RHEUMATOID ARTHRITIS: moderate-to-severe disease with a positive biomarker (RF or anti-CCP positive, or tested for RF + anti-CCP + CRP/ESR), or prior biologic/targeted synthetic therapy for RA. GIANT CELL ARTERITIS: diagnosis confirmed by temporal artery biopsy or cross-sectional imaging, OR acute-phase reactant elevation (high ESR and/or CRP). TB SCREENING REQUIRED for all indications: documented negative TST or IGRA within 12 months before initiating in biologic-naive patients. Do not initiate if ANC below 2000/mm3, platelets below 100,000/mm3, or ALT/AST above 1.5x ULN. GCA infusions exceeding 600 mg are not recommended. Reauthorization requires at least 20% improvement from baseline.
Diagnoses that commonly support medical necessity
ICD-10-CM diagnoses frequently associated with medical necessity for Tocilizumab (Actemra). Confirm the covered diagnosis list against the current Aetna policy.
Commonly required documentation
- Diagnosis with biomarker (RA) or biopsy/imaging/acute-phase reactants (GCA)
- negative TB test within 12 months
- baseline labs (ANC, platelets, transaminases).
Situations to verify before submitting
Aetna may not cover Tocilizumab (Actemra) in these situations. Verify against the current policy rather than assuming a denial:
- Should not be used in combination with biologic DMARDs (TNF antagonists, IL-1 receptor antagonists, anti-CD20 monoclonal antibodies, or selective co-stimulation modulators)
How to submit
- Method: Aetna precertification (Availity)
- Portal: Availity
Source
Source: Aetna CPB 0799 Tocilizumab (last review 2026-02-24). Code J3262. Last verified 2026-06-17.
Frequently asked questions
Does Aetna require prior authorization for Tocilizumab (Actemra)?
Yes. Aetna generally requires prior authorization for Tocilizumab (Actemra) (CPT J3262).
What does Aetna require to approve Tocilizumab (Actemra)?
Precertification required (prescribed by/with a rheumatologist for RA, GCA, polymyalgia rheumatica, or JIA). RHEUMATOID ARTHRITIS: moderate-to-severe disease with a positive biomarker (RF or anti-CCP positive, or tested for RF + anti-CCP + CRP/ESR), or prior biologic/targeted synthetic therapy for RA. GIANT CELL ARTERITIS: diagnosis confirmed by temporal artery biopsy or cross-sectional imaging, O… Always confirm against the current Aetna policy.
How long does a Aetna prior authorization take?
Turnaround varies by plan and submission method. Check the Aetna portal for current timeframes.
Submitting Tocilizumab (Actemra) to Aetna?
Praxigen checks your clinical note against these criteria before you submit and drafts a policy-cited appeal if it is denied. You review and submit; nothing is sent automatically.